NCT05536271View on ClinicalTrials.gov

Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

August 16, 2022

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Bisoprolol Fumarate

antihypertensive medicine prescribed for acute coronary syndrome patients

Trial Locations (1)

22511

Damanhour University, Damanhūr

All Listed Sponsors
collaborator

Alexandria University

OTHER

lead

Damanhour University

OTHER

NCT05536271 - Pharmacogenetic Study of Bisoprolol in Egyptian Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter